JP2016510765A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016510765A5 JP2016510765A5 JP2015561747A JP2015561747A JP2016510765A5 JP 2016510765 A5 JP2016510765 A5 JP 2016510765A5 JP 2015561747 A JP2015561747 A JP 2015561747A JP 2015561747 A JP2015561747 A JP 2015561747A JP 2016510765 A5 JP2016510765 A5 JP 2016510765A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- steroid
- halogen
- prednisolone
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/791,685 US9012432B2 (en) | 2013-03-08 | 2013-03-08 | Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis |
| US13/791,685 | 2013-03-08 | ||
| PCT/US2014/022169 WO2014138712A1 (en) | 2013-03-08 | 2014-03-07 | Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019071500A Division JP2019104762A (ja) | 2013-03-08 | 2019-04-03 | 変形性関節症の予防および治療のためのステロイドとゾレドロン酸との併用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016510765A JP2016510765A (ja) | 2016-04-11 |
| JP2016510765A5 true JP2016510765A5 (https=) | 2017-04-06 |
| JP6839491B2 JP6839491B2 (ja) | 2021-03-17 |
Family
ID=51488530
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015561747A Expired - Fee Related JP6839491B2 (ja) | 2013-03-08 | 2014-03-07 | 変形性関節症の予防および治療のためのステロイドとゾレドロン酸との併用 |
| JP2019071500A Pending JP2019104762A (ja) | 2013-03-08 | 2019-04-03 | 変形性関節症の予防および治療のためのステロイドとゾレドロン酸との併用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019071500A Pending JP2019104762A (ja) | 2013-03-08 | 2019-04-03 | 変形性関節症の予防および治療のためのステロイドとゾレドロン酸との併用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9012432B2 (https=) |
| EP (1) | EP2964209B1 (https=) |
| JP (2) | JP6839491B2 (https=) |
| KR (1) | KR102253394B1 (https=) |
| CN (1) | CN105324113B (https=) |
| AU (1) | AU2014225373B2 (https=) |
| BR (1) | BR112015021503B1 (https=) |
| CA (1) | CA2941346C (https=) |
| EA (1) | EA032067B1 (https=) |
| ES (1) | ES2904365T3 (https=) |
| MX (1) | MX377447B (https=) |
| WO (1) | WO2014138712A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10913772B2 (en) | 2016-03-09 | 2021-02-09 | Kine Sciences Co., Ltd. | Peptide for preventing or treating inflammatory diseases and use thereof |
| WO2017155234A1 (ko) | 2016-03-09 | 2017-09-14 | 주식회사 바이오펩 | 염증성 질환의 예방 또는 치료용 펩타이드 및 이의 용도 |
| US10913771B2 (en) | 2016-03-09 | 2021-02-09 | Kine Sciences Co., Ltd. | Peptide for preventing or treating inflammatory diseases and use thereof |
| KR101897122B1 (ko) | 2016-03-09 | 2018-09-10 | 주식회사 바이오펩 | 염증성 질환의 예방 또는 치료용 펩타이드 및 이의 용도 |
| CN108431020B (zh) | 2016-03-09 | 2022-03-29 | 凯恩塞恩斯株式会社 | 用于预防或治疗炎症性疾病的肽及其应用 |
| JP7127616B2 (ja) | 2019-06-04 | 2022-08-30 | 横河電機株式会社 | 情報処理装置、アラーム管理システム、及びアラーム管理方法 |
| WO2021163432A1 (en) * | 2020-02-12 | 2021-08-19 | Levolta Pharmaceuticals, Inc. | Co-administration of prednisolone/methyl prednisolone and zoledronic acid to treat and prevent osteoarthritis |
| CN114028571B (zh) * | 2021-11-18 | 2023-04-28 | 中国医学科学院基础医学研究所 | 含氮双膦酸盐联合糖皮质激素在预防或治疗病毒性肺炎中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2038692T4 (es) | 1986-11-21 | 2012-02-10 | Novartis Ag | Procedimiento para la obtencion de acidos alcanodifosfonicos substituidos. |
| US7018647B1 (en) * | 1999-12-27 | 2006-03-28 | Teikoku Seiyaku Co., Ltd | Patches for external use |
| GB0029111D0 (en) * | 2000-11-29 | 2001-01-10 | Novartis Ag | Organic compounds |
| EP1399162A2 (en) * | 2001-06-08 | 2004-03-24 | Ortho-McNeil Pharmaceutical, Inc. | Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
| AU2003226148A1 (en) * | 2002-04-05 | 2003-10-27 | Merck & Co., Inc. | Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
| CA2539359A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate |
| US20090035315A1 (en) * | 2004-06-17 | 2009-02-05 | Stephan Christgau | Method of Improving Treatments in Rheumatic and Arthritic Diseases |
| JP5240925B2 (ja) * | 2005-05-25 | 2013-07-17 | カロシン ファーマ， インコーポレイテッド | 変形性関節症を処置するための方法および組成物 |
| US20070048372A1 (en) * | 2005-08-18 | 2007-03-01 | Srz Properties, Inc. | Method for treating non-inflammatory osteoarthritic pain |
| UA96457C2 (ru) * | 2006-08-03 | 2011-11-10 | Нитек Фарма Аг | Лечение ревматоидного артрита глюкокортикоидами с отсроченным высвобождением |
| US20100158905A1 (en) * | 2008-12-19 | 2010-06-24 | Nuon Therapeutics, Inc. | Combination therapy of arthritis with tranilast |
| CN102427792A (zh) * | 2009-05-04 | 2012-04-25 | 扎斯制药公司 | 治疗与神经瘤、神经卡压及其他病况相关联的疼痛的方法 |
| US8946199B2 (en) | 2010-04-26 | 2015-02-03 | Ketan Desai | Co-administration of steroids and Zoledronic acid to prevent and treat side effects from Zoledronic acid infusion |
-
2013
- 2013-03-08 US US13/791,685 patent/US9012432B2/en active Active - Reinstated
-
2014
- 2014-03-07 EP EP14761174.3A patent/EP2964209B1/en active Active
- 2014-03-07 WO PCT/US2014/022169 patent/WO2014138712A1/en not_active Ceased
- 2014-03-07 ES ES14761174T patent/ES2904365T3/es active Active
- 2014-03-07 KR KR1020157027348A patent/KR102253394B1/ko not_active Expired - Fee Related
- 2014-03-07 JP JP2015561747A patent/JP6839491B2/ja not_active Expired - Fee Related
- 2014-03-07 CN CN201480026349.0A patent/CN105324113B/zh not_active Expired - Fee Related
- 2014-03-07 CA CA2941346A patent/CA2941346C/en active Active
- 2014-03-07 AU AU2014225373A patent/AU2014225373B2/en active Active
- 2014-03-07 EA EA201591638A patent/EA032067B1/ru not_active IP Right Cessation
- 2014-03-07 MX MX2015011671A patent/MX377447B/es active IP Right Grant
- 2014-03-07 BR BR112015021503-3A patent/BR112015021503B1/pt not_active IP Right Cessation
-
2019
- 2019-04-03 JP JP2019071500A patent/JP2019104762A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016510765A5 (https=) | ||
| JP2021522340A5 (https=) | ||
| US20250295869A1 (en) | Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer | |
| US8859530B2 (en) | Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis | |
| JP2019521139A5 (https=) | ||
| AU2024203637B2 (en) | Formulations of phosphoramidate derivatives of nucleoside drugs | |
| AU2014205529B2 (en) | Methods and compositions for treatment of demyelinating diseases | |
| CN103458896B (zh) | 用于治疗癌症的方法 | |
| JP2012176956A5 (https=) | ||
| JP2020517601A5 (https=) | ||
| JP2015536997A5 (https=) | ||
| JP2012525393A5 (https=) | ||
| JP2016510329A5 (https=) | ||
| KR102253394B1 (ko) | 골관절염의 예방 및 치료를 위한 스테로이드류 및 졸레드론산의 공투여 | |
| JP2011527345A5 (https=) | ||
| JP2017513809A5 (https=) | ||
| JP2017531689A5 (https=) | ||
| HRP20201307T1 (hr) | Upotreba reslizumaba za liječenje umjerene do ozbiljne eozinofilne astme | |
| JP2019520344A5 (https=) | ||
| JP2014530852A5 (https=) | ||
| JP2018522927A5 (https=) | ||
| JP2005516070A5 (https=) | ||
| CN116490165A (zh) | 阿比特龙前药 | |
| RU2015145135A (ru) | Лечение воспалительных расстройств | |
| JP2017515899A5 (https=) |